Gala Global Inc. (OTCPK:GLAG.D) entered into a definitive agreement to acquire 51% stake in Cryo Health USA, LLC on February 12, 2017. Under the terms of the agreement Gala Global will issue Series B Preferred Stock. The Parties will form a Subsidiary under Chill-N-Out Cryotherapy which will seek and develop acquisitions for Cyro Health and expand franchises. Gala Pharmaceutical, Inc. (OTCPK:GLPH) cancelled the acquisition of 51% stake in Cryo Health USA, LLC on February 12, 2018.